Skip to main content

Part of Cancer staging guidance sheets

Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)

Current Chapter

Current chapter – Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)


Stage grouping

This is the data sheet for TNM 9th edition staging of Gastrointestinal Stromal tumours (ICD10 C15-C20, C48.1-2).

For more detailed information regarding TNM staging, please see pages 129-132 of the UICC TNM 9 book.

 

Staging criteria for gastric tumours can be applied in primary, solitary omental GISTs. Staging criteria for intestinal tumours can be applied to GISTs in less common sites, such as oesophagus, colon, rectum and mesentery.

Gastric GIST (including primary omental)

Stage Group

T stage

N stage

M stage

Mitotic rate

Stage IA

T1, T2

N0

M0

Low

Stage IB

T3

N0

M0

Low

Stage II

T1, T2

N0

M0

High

 

T4

N0

M0

Low

Stage IIIA

T3

N0

M0

High

Stage IIIB

T4

N0

M0

High

Stage IV

Any T

N1

M0

Any rate

 

Any T

Any N

M1

Any rate

Non gastric (small intestine and other sites) GIST

Stage I

T1, T2

N0

M0

Low

Stage II

T3

N0

M0

Low

Stage IIIA

T1

N0

M0

High

 

T4

N0

M0

Low

Stage IIIB

T2, T3, T4

N0

M0

High

Stage IV

Any T

N1

M0

Any rate

 

Any T

Any N

M1

Any rate


TNM clinical classification

T- primary tumour

T value

Description

cTX

Primary tumour cannot be assessed

cT0

No evidence of primary tumour

cT1

Tumour 2 cm or less

cT2

Tumour more than 2 cm but not more than 5 cm

cT3

Tumour more than 5 cm but not more than 10 cm

cT4

Tumour more than 10 cm in greatest dimension

N - regional lymph nodes

N value

Description

cNX

Regional lymph nodes cannot be assessed*

cN0

No regional lymph node metastasis

cN1

Regional lymph node metastasis

Note

*NX: Regional lymph node involvement is rare for GISTs, so that is cases where the nodal status is not assessed clinically or pathologically could be considered cN0 instead of cNX or pNX

M - distant metastasis

M value

Description

cM0

No distant metastasis

cM1

Distant metastasis

 


TNM pathological classification

The pT and pN categories correspond to the cT and cN categories


G histopathology grading

Grading for GISTs is dependent on the mitotic rate

Low mitotic rate

5 or fewer per 5 mm2

High mitotic rate

Over 5 per 5 mm2


Download

Click on the box below to download a PDF version of this staging sheet:

Last edited: 16 January 2026 3:54 pm

  1. Cancer staging guidance sheets
  2. Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C09-14, C30-32)
  4. Pharynx (ICD10 C01, C02.4, C05.1-2, C09, C10.0, C10.2-3, C10.9, C11-13)
  5. Salivary glands (ICD10 C00-C14, C15.0, C30-C33, C41.1)
  6. Oesophagus including oesophagogastric junction (ICD10 C15, C16.0)
  7. Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)
  8. Stomach (ICD10 C16 - excluding C16.0)
  9. Small intestine (ICD10 C17)
  10. Appendix (ICD10 C18.1)
  11. Colon and rectum (ICD10 C18-C20)
  12. Anal and perianal skin (ICD10 C21)
  13. Liver (ICD10 C22.0)
  14. Intrahepatic bile ducts (ICD10 C22.1)
  15. Gallbladder (ICD10 C23)
  16. Distal extrahepatic bile duct (ICD10 C24.0)
  17. Perihilar bile ducts (ICD10 C24.0)
  18. Ampulla of vater (ICD10 C24.1)
  19. Pancreas (ICD10 C25)
  20. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  21. Larynx (ICD10 C32.0, C32.1, C32.2, C10.1)
  22. Lung (ICD10 C34)
  23. Thymus tumours (ICD10 C37.9)
  24. Soft tissues (ICD10 C15-C26, C34-C37 C38.1-3, C47-C49, C51-C53, C58, C60-C68)
  25. Bone (ICD10 C40, C41)
  26. Melanoma of skin (ICD10 C00.0-2, C00.6, C21.2, C43, C51, C60, C63.2)
  27. Merkel cell carcinoma of skin (ICD10 C00, C44, C51, C60, 63.2, C80)
  28. Skin carcinoma of the head and neck (ICD10 C00.0-2, C00.6, C44.0, C44.2-4)
  29. Carcinoma of skin of the eyelid (ICD10 C44.1)
  30. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  31. Pleural mesothelioma (ICD10 C38.4)
  32. Breast tumours (ICD10 C50)
  33. Vulva (ICD10 C51)
  34. Vagina (ICD10 C52)
  35. Cervix uteri (ICD10 C53)
  36. Uterine sarcomas
  37. Uterus - endometrium (ICD10 C54.1, C55)
  38. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  39. Gestational trophoblastic neoplasms (ICD10 C58)
  40. Penis tumours (ICD10 C60)
  41. Prostate tumours (ICD10 C61.9)
  42. Testis tumours (ICD10 C62)
  43. Kidney tumours (ICD10 C64)
  44. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  45. Urinary bladder tumours (ICD10 C67)
  46. Urethra tumours (ICD10 C68.0, C61.9)
  47. Carcinoma of conjuctiva (ICD10 C69.0)
  48. Melanoma of conjuctiva (ICD10 C69.0)
  49. Retinoblastoma (ICD10 C69.2)
  50. Melanoma of uvea (ICD10 C69.3-4)
  51. Carcinoma of lacrimal gland (ICD10 C69.5)
  52. Sarcoma of orbit (ICD10 C69.6)
  53. Thyroid gland (ICD10 C73.9)
  54. Adrenal cortex (ICD10 C74.0)
  55. Adrenal medulla and extra-adrenal paraganglia (ICD10 C74.1 C75.5)
  56. Parathyroid gland (ICD10 C75.0)
  57. Unknown primary - cervical nodes (ICD10 C77.0)
  58. Mycosis fungoides or sezary syndrome (ICD10 C84.0 and C84.1)
  59. T and B cutaneous lymphoma (ICD10, C82.6, C84.8, C86.6 and other C83-C86 if primary skin excluding C84.0 C84.1)
  60. Rhabdomyosarcoma (CTYA)
  61. Chronic lymphocytic leukaemia
  62. Hepatoblastoma (CTYA)
  63. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  64. Medulloblastoma
  65. Multiple myeloma
  66. Neuroblastoma
  67. Neuroendocrine tumours of the foregut
  68. Neuroendocrine tumours of the midgut and hindgut
  69. Non-hodgkin lymphoma (children)
  70. Wilms tumour of the kidney